Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham Lung Health Center, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Science. 2010 Oct 1;330(6000):90-4. doi: 10.1126/science.1190594. Epub 2010 Sep 2.
Leukotriene A(4) hydrolase (LTA(4)H) is a proinflammatory enzyme that generates the inflammatory mediator leukotriene B(4) (LTB(4)). LTA(4)H also possesses aminopeptidase activity with unknown substrate and physiological importance; we identified the neutrophil chemoattractant proline-glycine-proline (PGP) as this physiological substrate. PGP is a biomarker for chronic obstructive pulmonary disease (COPD) and is implicated in neutrophil persistence in the lung. In acute neutrophil-driven inflammation, PGP was degraded by LTA(4)H, which facilitated the resolution of inflammation. In contrast, cigarette smoke, a major risk factor for the development of COPD, selectively inhibited LTA(4)H aminopeptidase activity, which led to the accumulation of PGP and neutrophils. These studies imply that therapeutic strategies inhibiting LTA(4)H to prevent LTB(4) generation may not reduce neutrophil recruitment because of elevated levels of PGP.
白三烯 A(4)水解酶 (LTA(4)H) 是一种促炎酶,可生成炎症介质白三烯 B(4) (LTB(4))。LTA(4)H 还具有氨肽酶活性,但目前尚不清楚其底物和生理重要性;我们发现嗜中性粒细胞趋化因子脯氨酸-甘氨酸-脯氨酸 (PGP) 是这种生理底物。PGP 是慢性阻塞性肺疾病 (COPD) 的生物标志物,与肺内嗜中性粒细胞的持续存在有关。在急性嗜中性粒细胞驱动的炎症中,LTA(4)H 降解了 PGP,从而促进了炎症的消退。相比之下,香烟烟雾是 COPD 发展的主要危险因素,其选择性抑制了 LTA(4)H 的氨肽酶活性,导致 PGP 和嗜中性粒细胞的积累。这些研究表明,抑制 LTA(4)H 以防止 LTB(4)生成的治疗策略可能不会因 PGP 水平升高而减少中性粒细胞募集。